No medicine shortage for Pharmaniaga


Pharmaniaga Bhd group managing director Datuk Zulkarnain Md Eusope.

PETALING JAYA: There does not appear to be a shortage of medicines for Pharmaniaga Bhd.

The biggest pharmaceutical group said a good reason for the apparent shortage is quite likely due to people falling sick more often after lockdowns restrictions have been eased.

"During Covid-19, many stayed at home and there was much less an occurrence of sickness. This is based on the sales statistics of our antibiotics and medicines - last year these were very low. But when the lockdowns were eased, there is a higher occurrence of fever etc," its group managing director Datuk Zulkarnain Md Eusope said.

He noted that lockdowns were loosened at around the same time in many countries which is the reason why there was an apparent shortage.

"After Covid-19, an increased number of people have also become more health-conscious so they also do a stockpile of (medicines) in their own houses - this is more than usual before the pandemic," he added.

He said the group always had a three to six months inventory stock of active pharmaceutical ingredients (API) which is required to manufacture pharmaceutical drugs.

"We are actively studying and monitoring the API price - we always have a few suppliers in case of any shortage or fluctuations in price," he said.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Pharmaniaga , pharmaceutical , medicines

Next In Business News

Pure passive investing era ends
AI’s power dilemma
The jury is still out
Sports apparel on the up and up
Singapore banks a steady dividend play
The advanced packaging race
Can My Value Up re-rate Bursa Malaysia?
Too much of a good thing�
Looking beyond Europe’s chipmakers
Can Wall Street keep rally alive?

Others Also Read